Clinical trial
Memantine and Down's Syndrome
NCT00240760 · King's College London, Other · Unknown status
Key facts
| NCT number | NCT00240760 |
|---|---|
| Title | Memantine and Down's Syndrome |
| Official title | Efficacy and Safety of Memantine Hydrochloride, a Low Affinity Antagonist to N-Methyl-D-Aspartate (NMDA) Type Receptors, in the Prevention of Cognitive Decline and Disease Progression in Down's Syndrome |
| Lead sponsor | King's College London, Other |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Down's Syndrome, Dementia, Learning Disabilities |
| Intervention type | Drug |
| Interventions | Memantine Hydrochloride |
| Enrollment | 180 |
| Start date | Oct 1, 2005 |
| First posted | Oct 18, 2005 |
| Last update posted | Feb 20, 2006 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: